Clinical Trial Update: Efficacy and Tolerability of Cisplatin Plus Alternating Weekly Temozolomide in Recurrent High-grade Gliomas [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cisplatin plus alternating weekly temozolomide shows efficacy and tolerability in patients with recurrent high-grade gliomas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Glioma

Drugs mentioned

• CISPLATIN (cisplatin)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Huashan Hospital | Conditions: High-grade Gliomas | Phase 2 | Status: COMPLETED